More on REGn
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $649.81 |
|
|||
| Open | $663.18 | ||||
| 52 Wk High | $592.36 | ||||
| 52 Wk Low | $325.35 | ||||
| Day High | $677.92 | ||||
| Day Low | $659.02 | ||||
| P/E | 177.49 | ||||
| EPS | $3.81 | ||||
| Volume | 918,463 | ||||
- Form 4 REGENERON PHARMACEUTICAL For: Jul 02 Filed by: RYAN ARTHUR F
- Regeneron Pharma (REGN) PT Lowered to $696 at RBC Capital
- Regeneron Pharma (REGN) PT Lowered to $769 at Truist Securities
- Form 8-K REGENERON PHARMACEUTICAL For: Jul 06
- Regeneron Pharma (REGN) PT Lowered to $750 at Cantor Fitzgerald on Negative Eylea Optics
- Regeneron Pharma (REGN) PT Lowered to $800 at HSBC
- Form 144 REGENERON PHARMACEUTICAL Filed by: RYAN ARTHUR F
- FDA selects 7 companies for domestic drug manufacturing pilot
- From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak
- Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
Entities mentioned with REGN
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Genzyme/Sanofi-Aventis | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
